Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Passes Below 50-Day Moving Average – Here’s Why

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) shares crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $13.97 and traded as low as $13.6640. Bayer Aktiengesellschaft shares last traded at $13.76, with a volume of 208,956 shares changing hands.

Wall Street Analyst Weigh In

BAYRY has been the subject of a number of analyst reports. Zacks Research raised Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 10th. Jefferies Financial Group upgraded shares of Bayer Aktiengesellschaft to a “hold” rating in a report on Friday, May 29th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a research report on Thursday, July 2nd. Two investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy”.

Bayer Aktiengesellschaft Stock Down 2.6%

The firm has a 50-day moving average price of $13.97 and a two-hundred day moving average price of $12.33. The firm has a market cap of $54.08 billion, a price-to-earnings ratio of -26.98, a price-to-earnings-growth ratio of 2.07 and a beta of 0.56. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.67 and a current ratio of 1.04.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.23 by $0.06. Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 16.77%. The company had revenue of $12.53 billion for the quarter, compared to analyst estimates of $12.31 billion. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS. On average, sell-side analysts forecast that Bayer Aktiengesellschaft will post 1.28 earnings per share for the current year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863, the company develops and markets products in healthcare and agriculture and serves customers in markets around the world. Bayer’s American depositary shares trade over the counter under the symbol BAYRY.

The company operates through three principal areas: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals business develops prescription medicines in areas such as cardiovascular disease, women’s health, oncology, neurology and specialty therapeutics.